PharmaResearch Co., Ltd. (KOSDAQ: 214450)

PharmaResearch Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,155,852	1,116,952	697,316	818,025	552,155	343,774
Market Cap Growth	5.17%	60.18%	-14.76%	48.15%	60.62%	7.92%
Enterprise Value	2,013,186	990,868	612,568	761,136	536,011	317,055
Last Close Price	207500.00	109500.00	69286.84	80515.43	55760.85	35180.89
PE Ratio	25.07	14.60	17.04	17.08	16.18	19.92
Forward PE	17.33	12.55	10.92	14.49	15.04	21.28
PS Ratio	7.14	4.28	3.58	5.31	5.08	4.10
PB Ratio	4.44	2.42	1.88	2.49	2.09	1.50
P/TBV Ratio	3.40	2.77	2.27	3.10	2.67	2.08
P/FCF Ratio	27.22	21.12	16.54	18.32	-	35.49
P/OCF Ratio	14.69	17.20	11.74	12.53	17.05	17.84
EV/Sales Ratio	6.79	3.80	3.15	4.94	4.93	3.78
EV/EBITDA Ratio	16.18	9.50	8.01	12.27	12.83	11.85
EV/EBIT Ratio	17.99	10.74	9.29	14.50	16.04	16.63
EV/FCF Ratio	25.42	18.74	14.53	17.05	-	32.73
Debt / Equity Ratio	0.07	0.07	0.18	0.20	0.12	0.09
Debt / EBITDA Ratio	0.30	0.33	0.87	1.06	0.78	0.78
Debt / FCF Ratio	0.44	0.65	1.58	1.47	-	2.16
Asset Turnover	0.54	0.52	0.43	0.41	0.37	0.32
Inventory Turnover	1.81	1.89	2.55	2.40	2.07	2.58
Quick Ratio	2.85	2.96	4.04	3.86	2.87	4.82
Current Ratio	3.68	3.89	4.56	4.31	3.55	5.62
Return on Equity (ROE)	19.64%	18.53%	12.41%	15.80%	13.17%	6.64%
Return on Assets (ROA)	11.91%	11.38%	9.10%	8.78%	7.08%	4.51%
Return on Capital (ROIC)	13.02%	12.33%	9.90%	9.50%	7.65%	4.88%
Earnings Yield	3.99%	6.85%	5.82%	5.71%	5.94%	4.85%
FCF Yield	3.67%	4.73%	6.04%	5.46%	-0.43%	2.82%
Dividend Yield	0.43%	0.87%	0.95%	0.75%	0.90%	0.85%
Payout Ratio	11.54%	9.84%	15.56%	10.77%	9.05%	17.84%
Buyback Yield / Dilution	-6.77%	-5.85%	0.76%	-5.74%	-0.73%	3.54%
Total Shareholder Return	-6.33%	-4.98%	1.72%	-5.00%	0.17%	4.39%

Source: S&P Capital IQ. Standard template. Financial Sources.